ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,337, issued on May 26, was assigned to EXOCOBIO INC. (Seoul, South Korea).
"Composition for anti-inflammation, wound healing or wound healing promotion, comprising rose stem cell-derived exosomes as active ingredient" was invented by Byong Seung Cho (Gunpo-si Gyeonggi-do, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "A composition containing rose stem cell-derived exosomes as an active ingredient is provided for anti-inflammation, wound healing or wound healing acceleration. The composition has excellent effects on anti-inflammation, wound healing and/or wound healing acceleration."
The patent was filed on Nov. 23, 2022, under Applicati...